<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neural Plast</journal-id>
<journal-id journal-id-type="iso-abbrev">Neural Plast</journal-id>
<journal-id journal-id-type="publisher-id">NP</journal-id>
<journal-title-group>
<journal-title>Neural Plasticity</journal-title>
</journal-title-group>
<issn pub-type="ppub">2090-5904</issn>
<issn pub-type="epub">1687-5443</issn>
<publisher>
<publisher-name>Hindawi Publishing Corporation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26881141</article-id>
<article-id pub-id-type="pmc">4736967</article-id>
<article-id pub-id-type="doi">10.1155/2016/9603751</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synaptic Wnt/GSK3<italic>β</italic> Signaling Hub in Autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Caracci</surname>
<given-names>Mario O.</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ávila</surname>
<given-names>Miguel E.</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Ferrari</surname>
<given-names>Giancarlo V.</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="I1"><sup>1</sup>Center for Biomedical Research, Faculty of Biological Sciences and Faculty of Medicine, Universidad Andres Bello, P.O. Box 8370134, Santiago, Chile</aff>
<aff id="I2"><sup>2</sup>FONDAP Center for Genome Regulation, Santiago, Chile</aff>
<author-notes>
<corresp id="cor1">*Giancarlo V. De Ferrari: <email>gdeferrari@unab.cl</email></corresp>
<fn fn-type="other">
<p>Academic Editor: Preston E. Garraghty</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>1</month>
<year>2016</year>
</pub-date>
<volume>2016</volume>
<elocation-id>9603751</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>29</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Mario O. Caracci et al.</copyright-statement>
<copyright-year>2016</copyright-year>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Hundreds of genes have been associated with autism spectrum disorders (ASDs) and the interaction of weak and<italic> de novo</italic> variants derive from distinct autistic phenotypes thus making up the “spectrum.” The convergence of these variants in networks of genes associated with synaptic function warrants the study of cell signaling pathways involved in the regulation of the synapse. The Wnt/<italic>β</italic>-catenin signaling pathway plays a central role in the development and regulation of the central nervous system and several genes belonging to the cascade have been genetically associated with ASDs. In the present paper, we review basic information regarding the role of Wnt/<italic>β</italic>-catenin signaling in excitatory/inhibitory balance (E/I balance) through the regulation of pre- and postsynaptic compartments. Furthermore, we integrate information supporting the role of the glycogen synthase kinase 3<italic>β</italic> (GSK3<italic>β</italic>) in the onset/development of ASDs through direct modulation of Wnt/<italic>β</italic>-catenin signaling. Finally, given GSK3<italic>β</italic> activity as key modulator of synaptic plasticity, we explore the potential of this kinase as a therapeutic target for ASD. </p>
</abstract>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>1. Introduction</title>
<p>Autism spectrum disorders (ASDs) are highly heterogeneous, pervasive developmental disorders characterized by impaired social communication skills, repetitive behaviors, and a restricted range of interests [<xref ref-type="bibr" rid="B1">1</xref>]. The wide range of phenotypical traits regarding comorbidities and various degrees of cognitive and language impairments makes up the “spectrum” and adds complexity to the determination of genetic markers associated with a distinct phenotype [<xref ref-type="bibr" rid="B2">2</xref>]. ASDs have a strong genetic component as ascertained by a 90% concordance among monozygotic twins [<xref ref-type="bibr" rid="B3">3</xref>]. Significant advancements have been made in identifying molecular mechanisms involved in ASDs by studying disorders with Mendelian inheritance patterns such as Tuberous Sclerosis complex (<italic>TSC1 </italic>and<italic> TSC2</italic>), Rett syndrome (<italic>MECP2</italic>), Fragile X syndrome (FXS; which results from mutated Fragile X mental retardation-1,<italic> FMR1</italic>), and Cowden syndrome (<italic>PTEN</italic>), but, altogether, these disorders do not account for more than 10% of cases [<xref ref-type="bibr" rid="B4">4</xref>]. In the last few years, efforts have focused on understanding the genetic contribution of single nucleotide variants (SNVs) and copy number variants (CNVs) in ASD [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>]. While genome wide association studies (GWAS) have identified over 100 genes associated with ASDs, most of the variants identified have a weak effect suggesting a greater contribution for rare variants [<xref ref-type="bibr" rid="B7">7</xref>]. Rare variants and<italic> de novo</italic> occurring SNVs and CNVs have a larger contribution to the onset of ASD [<xref ref-type="bibr" rid="B6">6</xref>]. Indeed,<italic> de novo</italic> CNVs are significantly enriched in individuals affected with the disorder and it is estimated that 8% of cases that carry these variants are likely to be pathogenic [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. On the other hand, 9% of<italic> de novo</italic> SNVs in affected individuals are disruptive or frameshift mutations that generate nonconserved amino acid changes such as premature stop codons or alternative splice sites ultimately affecting the normal biological function of the resulting protein [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. Overall, it is estimated that these deleterious<italic> de novo</italic> variants affect ASD susceptibility in 10–15% of probands [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. Nevertheless, exomic data suggests that no single gene could account for more than 1% of ASD cases, which makes it difficult to target a single protein to treat autistic behaviors. More recently, the integration of these genes into functional networks has allowed the identification of specific molecular pathways that could be disrupted in ASD [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. In this regard, recent exome sequencing studies in family trios identified that 39% of the more disruptive<italic> de novo</italic> mutations are part of an interconnected network of chromatin remodeling, synaptic plasticity, and Wnt/<italic>β</italic>-catenin signaling genes [<xref ref-type="bibr" rid="B13">13</xref>–<xref ref-type="bibr" rid="B15">15</xref>].</p>
<p>Through the analysis of biochemical and pharmacological data, animal models of the disease, and genetic association studies, we predicted earlier that the onset/development of ASDs might involve the additive effect of genetic variants within Wnt/<italic>β</italic>-catenin signaling components and/or genes coding for molecules that modulate its functional activity [<xref ref-type="bibr" rid="B16">16</xref>], and such hypothesis has received considerable attention recently [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>]. Wnts are lipid modified secreted glycoproteins that signal through three major pathways: the Planar Cell Polarity (PCP), Wnt/Ca<sup>+2</sup>, and the canonical Wnt/<italic>β</italic>-catenin signaling pathway [<xref ref-type="bibr" rid="B19">19</xref>]. Wnt/<italic>β</italic>-catenin signaling is the most well understood cascade and it starts via binding of the Wnt ligand to cell membrane receptors Frizzled (<italic>FZD</italic>), belonging to the 7-transmembrane domains family of proteins and to members of the low density lipoprotein receptor related proteins 5 and 6 (<italic>LRP5</italic>/<italic>6</italic>), which act as coreceptors [<xref ref-type="bibr" rid="B20">20</xref>]. Wnt binding to its membrane receptor activates intracellular signaling leading to the dissociation of <italic>β</italic>-catenin from the degradation complex consisting of Axin and adenomatous polyposis coli (APC) scaffolds [<xref ref-type="bibr" rid="B21">21</xref>], and the serine-threonine kinases casein kinase 1 (CK1) and glycogen synthase kinase 3<italic>β</italic> (GSK3<italic>β</italic>) [<xref ref-type="bibr" rid="B22">22</xref>]. As a net result, <italic>β</italic>-catenin accumulates in the cytosol and translocates to the nucleus where it interacts with T-cell factor/lymphoid enhancing factor (TCF/LEF) transcription factors to activate transcription of target genes [<xref ref-type="bibr" rid="B23">23</xref>]. Conversely, in the absence of a Wnt ligand, Axin and APC facilitate CK1 and GSK3<italic>β</italic> sequential phosphorylation of <italic>β</italic>-catenin [<xref ref-type="bibr" rid="B22">22</xref>] targeting the protein for ubiquitination by the <italic>β</italic>-transducing repeat-containing protein (<italic>β</italic>-TrCP) and subsequent proteasome degradation [<xref ref-type="bibr" rid="B24">24</xref>].</p>
<p>It is interesting to note that the tumor suppressor complex formed by TSC1 and TSC2 interacts with the <italic>β</italic>-catenin degradation complex and thus modulates the action of Wnt signaling [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. Other genetic elements associated with ASDs are the canonical Wnt2 ligand [<xref ref-type="bibr" rid="B27">27</xref>], the hepatocyte growth factor receptor (MET) [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>], which is a target gene of Wnt/<italic>β</italic>-catenin signaling [<xref ref-type="bibr" rid="B30">30</xref>], and several genes encoding for cadherins, including<italic> CDH5</italic>,<italic> CDH8</italic>,<italic> CDH9</italic>,<italic> CDH10</italic>,<italic> CDH13</italic>,<italic> CDH15</italic>,<italic> PCDH10</italic>,<italic> PCDH19,</italic> and<italic> PCDHb4</italic> [<xref ref-type="bibr" rid="B31">31</xref>], some of which may interact with <italic>β</italic>-catenin in cell-cell adhesion complexes. More recently, the chromo-helicase domain protein 8 (CHD8) [<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B32">32</xref>], which inhibits <italic>β</italic>-catenin through direct binding [<xref ref-type="bibr" rid="B33">33</xref>], and DYRK1A that modulates Wnt signaling through interaction with the p120 catenin [<xref ref-type="bibr" rid="B34">34</xref>] have been found to be associated with ASDs. Interestingly, these genes harbor recurrent disruptive mutations and display a high correlation with head size abnormalities [<xref ref-type="bibr" rid="B14">14</xref>], which is a feature commonly observed during the first 2-3 years of life of an ASD individual [<xref ref-type="bibr" rid="B35">35</xref>]. Finally, rare<italic> de novo</italic> genetic variants in the <italic>β</italic>-catenin (<italic>CTNNB1</italic>) gene itself have been implicated in severe intellectual disability [<xref ref-type="bibr" rid="B36">36</xref>]. Therefore, the convergence of genetic markers in synaptic components opens a therapeutic window that aims not only to correct developmental brain abnormalities, but also to compensate the inherent plasticity through modulation of the highly dynamic synapse. In the present paper, we review current knowledge of synaptic transmission leading to excitatory and inhibitory (E/I) imbalance commonly seen in ASD and how this phenomenon relates to dysfunction of the Wnt/<italic>β</italic>-catenin pathway. Furthermore, we trace functional defects to GSK3<italic>β</italic> activity and explore its pharmacological regulation as a potential therapeutic target for ASD, particularly in relation to synaptic plasticity.</p>
</sec>
<sec id="sec2">
<title>2. Wnt/<bold><italic>β</italic></bold>-Catenin Signaling and Synaptic Transmission Defects in ASDs</title>
<p>The inherent ability of the brain to process information is accomplished by a highly sophisticated network that allows long-distance communication between cells and which is largely based on the E/I balance from neuronal connections. Genetic, functional, and structural information suggests that the E/I balance may underlie the symptomatology of ASDs [<xref ref-type="bibr" rid="B37">37</xref>–<xref ref-type="bibr" rid="B39">39</xref>]. This idea has been examined through optogenetic methods in the medial prefrontal cortex of mice, and it was found that the elevation, but not the reduction, of cellular E/I balance (i.e., increase in excitatory transmission) induced cellular defects in information processing, leading to behavioral and social deficits [<xref ref-type="bibr" rid="B39">39</xref>]. E/I balance anomalies have similarly been observed in several ASD animal models, including the neuroligin 3 (<italic>NLGN3</italic>) mutant mice, and the models for Rett, Fragile X, and Angelman syndromes (Rev. in [<xref ref-type="bibr" rid="B40">40</xref>]). In humans, one of the most relevant evidence associating the E/I balance with ASDs is its high comorbidity with epilepsy (30% comorbidity with ASDs) [<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. Epileptic activity can be triggered by blocking synaptic inhibitory transmission or by activating excitatory transmission linking the E/I imbalance in the establishment of epileptiform seizures [<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>Wnt signaling has been widely acknowledged during patterning, development, and maturation of functional synapses within the CNS [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B44">44</xref>–<xref ref-type="bibr" rid="B48">48</xref>]. Wnt1, Wnt3a, Wnt7a, and Wnt8 are ligands known to activate Wnt/<italic>β</italic>-catenin signaling and are involved in brain development and synaptogenesis [<xref ref-type="bibr" rid="B49">49</xref>–<xref ref-type="bibr" rid="B51">51</xref>]. Wnt7a and Wnt8a have also been shown to regulate excitatory synaptic formation [<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B52">52</xref>]. Furthermore, a recent study suggests that LRP6, Wnt/<italic>β</italic>-catenin signaling coreceptor, is critical for the development of functional synapses<italic> in vivo</italic> [<xref ref-type="bibr" rid="B52">52</xref>], which further supports the involvement of Wnt/<italic>β</italic>-catenin signaling in synaptic development. Interestingly tetanic stimulation induces the release of the Wnt3a ligand from the postsynaptic terminal [<xref ref-type="bibr" rid="B53">53</xref>]. We demonstrated later that treatment with purified Wnt3a protein of cultured hippocampal neurons enhanced a fast influx of Ca<sup>2+</sup> in the presynaptic terminal and enhanced mEPSC frequency at the postsynaptic terminal, in an LRP6-dependent mechanism [<xref ref-type="bibr" rid="B54">54</xref>]. Hence, the data suggests a prominent role for Wnt/<italic>β</italic>-catenin signaling in the regulation of excitatory synaptic transmission in pre- and postsynaptic compartments, thus ascribing a role for the signaling cascade in E/I balance regulation (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
</sec>
<sec id="sec3">
<title>3. ASDs and Wnt Signaling at the Presynaptic Terminal </title>
<p>At the presynaptic region, canonical Wnt signaling has a major role in clustering and recycling of synaptic vesicles (SVs). Conditioned media containing Wnt7a, and to a lesser extent Wnt3a, were found to enhance SVs recycling in primary cultures of rat hippocampal neurons [<xref ref-type="bibr" rid="B55">55</xref>]. Similarly, loss of Wnt7a function inhibits SVs clustering, an effect that is mimicked by loss of function of Dishevelled 1 (<italic>DVL1</italic>) signaling downstream of Wnt ligands [<xref ref-type="bibr" rid="B47">47</xref>]. Interestingly, Dvl1 knockout mice exhibit social interaction and sensorimotor abnormalities [<xref ref-type="bibr" rid="B56">56</xref>]. Moreover, the Wnt7a/Dvl1 double mutant mice show defects in spine morphogenesis and excitatory synaptic neurotransmission [<xref ref-type="bibr" rid="B45">45</xref>], which parallels behavioral abnormalities with a disrupted presynaptic assembly and E/I balance, as it is likely observed in ASDs.</p>
<p>Wnt/<italic>β</italic>-catenin signaling also seems to trigger neurotransmitter release and SV trafficking by modulating the function of SVs-associated phosphoproteins, including membrane-trafficking proteins such as synapsin and synaptotagmin. While all three members of the synapsin (SYN) gene family (<italic>SYN1-3</italic>) [<xref ref-type="bibr" rid="B57">57</xref>] have been associated with ASDs [<xref ref-type="bibr" rid="B58">58</xref>–<xref ref-type="bibr" rid="B60">60</xref>], it has been shown that canonical Wnt ligands such as Wnt7a and Wnt3a enhance the clustering [<xref ref-type="bibr" rid="B61">61</xref>] and phosphorylation [<xref ref-type="bibr" rid="B54">54</xref>] of Syn1 at the synaptic button prior to neurotransmitter release. Likewise,<italic> SYN2</italic> is predicted as a Wnt/<italic>β</italic>-catenin target gene [<xref ref-type="bibr" rid="B62">62</xref>] and is upregulated as a consequence of enhanced Wnt signaling activity in hippocampal neurons from APC conditional knockout mice that has impaired learning and memory and that displays ASD-like behaviors [<xref ref-type="bibr" rid="B63">63</xref>]. Finally, it was shown that the Wnt signaling component Dvl1 is involved in neurotransmitters release at the tip of neurites of differentiated neurons through direct binding to the presynaptic protein synaptotagmin I [<xref ref-type="bibr" rid="B64">64</xref>].</p>
<p>Other mechanisms modulating the activity of the presynaptic terminal involve the function of cell adhesion proteins, most notably trans-synaptic cadherin interactions. It is widely accepted that cadherin-<italic>β</italic>-catenin adhesion complexes have an essential function during the recruitment and clustering of SVs to synapses [<xref ref-type="bibr" rid="B65">65</xref>–<xref ref-type="bibr" rid="B69">69</xref>]. Indeed, ablation of <italic>β</italic>-catenin results in the mislocalization of SVs along the axon, while clustering of active zone proteins like Bassoon is unchanged [<xref ref-type="bibr" rid="B68">68</xref>]. Tyrosine 654 phosphorylation of <italic>β</italic>-catenin weakens cadherin-catenin interactions [<xref ref-type="bibr" rid="B70">70</xref>]. Interestingly, the tyrosine kinase FER, which is an ASDs' candidate gene [<xref ref-type="bibr" rid="B71">71</xref>], activates the tyrosine phosphatase SHP-2 which removes <italic>β</italic>-catenin phosphorylation and strengthens cadherin mediated adhesion [<xref ref-type="bibr" rid="B72">72</xref>]. Among other proteins modulating <italic>β</italic>-catenin dissociation from cell adhesion complexes that have been genetically linked with ASD is the MET receptor tyrosine kinase [<xref ref-type="bibr" rid="B30">30</xref>], which phosphorylates Tyr142 in <italic>β</italic>-catenin and promotes its dissociation from cadherins [<xref ref-type="bibr" rid="B73">73</xref>], thus linking regulation of cell adhesion by catenins in the pathophysiology of ASDs. In sum, the data available indicates an essential role for Wnt/<italic>β</italic>-catenin signaling in synaptic structure stability and function through modulating cell adhesion, vesicle exocytosis, and clustering well beyond <italic>β</italic>-catenin functioning solely as a TCF/LEF transcriptional coactivator.</p>
</sec>
<sec id="sec4">
<title>4. ASDs and Wnt Signaling at the Postsynaptic Terminal</title>
<p>Experience driven plasticity is highly dependent on proper synaptic transmission and is mainly modulated by Ca<sup>2+</sup> related pathways. Canonical and noncanonical Wnt pathways have been extensively related to Ca<sup>2+</sup> homeostasis and signaling [<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>]. Ligands such as Wnt3a [<xref ref-type="bibr" rid="B54">54</xref>], Wnt5a [<xref ref-type="bibr" rid="B75">75</xref>], and Wnt7a [<xref ref-type="bibr" rid="B47">47</xref>] have all been shown to increase Ca<sup>2+</sup> influxes in neurons. It is accepted that activation of L-type voltage sensitive Ca<sup>2+</sup> channels (L-VSCCs) or NMDA receptors allows the entrance of Ca<sup>2+</sup> which in turn activate CAMKII triggering actin cytoskeleton reorganization to regulate dendritic growth [<xref ref-type="bibr" rid="B76">76</xref>]. In this regard, CAMKII and the Wnt target gene CAMKIV [<xref ref-type="bibr" rid="B77">77</xref>] activate transcription factors such as CREB to start activity dependent transcription to further promote synaptic development [<xref ref-type="bibr" rid="B78">78</xref>]. CAMKIV has been associated with ASD [<xref ref-type="bibr" rid="B79">79</xref>] and additionally it mediates <italic>β</italic>-catenin dependent dendritic growth upon Ca<sup>2+</sup> influx [<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B80">80</xref>].</p>
<p>Activation of CAMKII and other kinases through NMDAR-mediated Ca<sup>2+</sup> influx is an event preceding the establishment of long-term synaptic potentiation (LTP) that allows the recruitment of AMPARs at the postsynaptic terminal, which in turn enhances long lasting excitatory transmission [<xref ref-type="bibr" rid="B81">81</xref>]. Additionally, CAMKII robustly phosphorylates the cell adhesion neuroligin 1 (<italic>NLGN1</italic>) protein increasing its surface expression [<xref ref-type="bibr" rid="B82">82</xref>]. Notably, suppression of Wnt/<italic>β</italic>-catenin signaling impairs LTP and conversely its activation facilitates it [<xref ref-type="bibr" rid="B53">53</xref>], and both enhanced and diminished LTP have been observed in animal models of ASD. For instance, given that enhanced LTP has been observed in TSC2 mutant model [<xref ref-type="bibr" rid="B83">83</xref>] and that<italic> TSC2</italic> missense mutations fail to inhibit the Wnt pathway [<xref ref-type="bibr" rid="B26">26</xref>], it is likely that overactivation of the signaling cascade may enhance LTP in this specific model. In contrast, mutant models for Fragile X mental retardation-1 (<italic>FMR1</italic>), and also for the disrupted in schizophrenia 1 (<italic>DISC1</italic>) genes, exhibit diminished capacity to establish LTP [<xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B85">85</xref>]. Besides their putative role in schizophrenia, ASDs and other neurological diseases [<xref ref-type="bibr" rid="B86">86</xref>–<xref ref-type="bibr" rid="B88">88</xref>], common<italic> DISC1</italic> genetic variants, directly impact Wnt/<italic>β</italic>-catenin signaling function (see below) [<xref ref-type="bibr" rid="B89">89</xref>]. Altogether, the data suggest that the Wnt/<italic>β</italic>-catenin pathway plays a central role in Ca<sup>2+</sup> homeostasis at postsynaptic terminals, which is commonly disrupted in ASD. In addition, abnormal establishment of LTP, phenomenon in which the signaling cascade plays an important role, has profound effects in activity driven plasticity affecting efficient synaptic transmission and disrupting the E/I balance.</p>
<p>LTP is the most well understood paradigm of activity driven plasticity and is considered to be one of the synaptic mechanisms underlying learning and memory [<xref ref-type="bibr" rid="B81">81</xref>]. In turn, several aspects of the ASD core symptomatology and the high comorbidity with intellectual disability disorder could be explained by defective memory mechanisms [<xref ref-type="bibr" rid="B90">90</xref>]. Indeed, diminished episodic memory has been reported for high functioning ASD individuals and is thought to impair the relational binding of elements comprising complex stimuli [<xref ref-type="bibr" rid="B91">91</xref>]. Therefore, rescuing defects in LTP that appears to be highly regulated by the Wnt/<italic>β</italic>-catenin pathway specifically through the modulation of GSK3<italic>β</italic> could improve core ASD symptomatology and open a therapeutic window for the treatment of ASD through the fine-tuning of synaptic plasticity.</p>
</sec>
<sec id="sec5">
<title>5. Synaptic Wnt/GSK3<bold><italic>β</italic></bold> Signaling Hub in ASD</title>
<p>GSK3 is an evolutionary conserved serine/threonine kinase highly abundant in the brain. Two homologous isoforms, GSK3<italic>α</italic> and GSK3<italic>β</italic>, have been described in mammals and are involved in multiple cellular processes including glycogen metabolism, gene transcription, microtubule stability, and apoptosis [<xref ref-type="bibr" rid="B92">92</xref>]. GSK3<italic>β</italic> is as a convergence point of major prevalent neurological disorders, including Alzheimer's disease, schizophrenia, and bipolar disorder [<xref ref-type="bibr" rid="B93">93</xref>–<xref ref-type="bibr" rid="B95">95</xref>], and its activity is negatively regulated by Wnt signaling. As mentioned before, the<italic> DISC1</italic> gene has an essential role in modulating brain structure and function and when mutated leads to neuropsychiatric behavior. DISC1 inhibits GSK3<italic>β</italic> activity by direct physical interaction resulting in reduced <italic>β</italic>-catenin phosphorylation and activation of Wnt/<italic>β</italic>-catenin signaling cascade [<xref ref-type="bibr" rid="B96">96</xref>] and common genetic variants affecting the coding sequence of the gene were found to suppress Wnt/<italic>β</italic>-catenin signaling activity [<xref ref-type="bibr" rid="B89">89</xref>]. Regarding ASDs, hyperactivation of GSK3<italic>β</italic> has been documented in animal models of FXS [<xref ref-type="bibr" rid="B97">97</xref>–<xref ref-type="bibr" rid="B99">99</xref>]. For instance, knock in mice expressing constitutively active form of GSK3<italic>β</italic> displays similar social preference abnormalities as FMR1 KO mice [<xref ref-type="bibr" rid="B99">99</xref>].</p>
<p>Mouse models for Fragile X, Phellan-McDermid, and Angelman syndromes, as well as for Tuberous Sclerosis, all present an abnormal number of dendritic spines that suggest a dysregulation in synaptic turnover [<xref ref-type="bibr" rid="B100">100</xref>–<xref ref-type="bibr" rid="B102">102</xref>]. In this regard, postnatal ablation of GSK3<italic>β</italic> in mice forebrain has anxiolytic and prosocial effects [<xref ref-type="bibr" rid="B103">103</xref>] and its overexpression accounts for spatial learning deficits in the Morris water maze paradigm [<xref ref-type="bibr" rid="B104">104</xref>]. Interestingly, forebrain deletion of GSK3<italic>β</italic> leads to reduced spine density where persistent spines are lost and newly formed spines are unstable [<xref ref-type="bibr" rid="B105">105</xref>]. These structural abnormalities are accompanied by a drop in AMPA dependent mEPSC and the effect is mimicked by the expression of constitutively active <italic>β</italic>-catenin [<xref ref-type="bibr" rid="B105">105</xref>]. Furthermore, pharmacological inhibition of GSK3<italic>β</italic> has been shown to increase internalization of NMDA and AMPA receptors, effect that is mainly observed for NR2B containing receptors [<xref ref-type="bibr" rid="B106">106</xref>]. Conversely, activation of GSK3<italic>β</italic> impairs the establishment of LTP [<xref ref-type="bibr" rid="B107">107</xref>] and high frequency stimulation inhibits GSK3<italic>β</italic> in a Ca<sup>2+</sup> dependent mechanism [<xref ref-type="bibr" rid="B108">108</xref>]. Given that increased abnormal spine density is a pathological hallmark in ASD that may lead to brain hyperconnectivity underlying the basis for E/I balance, the data suggests that inhibition of the Wnt/<italic>β</italic>-catenin signaling through hyperactivation of GSK3<italic>β</italic> might help to explain transmission anomalies as it is observed in ASD.</p>
</sec>
<sec id="sec6">
<title>6. Pharmacological Regulation of GSK3<bold><italic>β</italic></bold> in ASD</title>
<p>Due to its high heterogeneity, genetic factors cannot be held accountable for the entire spectrum of autism suggesting a role for environmental factors in the onset of ASD.<italic> In utero</italic> exposure to anticonvulsive medication is known to cause neurodevelopmental abnormalities [<xref ref-type="bibr" rid="B109">109</xref>]. The most well studied anticonvulsive agent in these subjects is valproic acid (valproate, VPA), a known inhibitor of GSK3<italic>β</italic> [<xref ref-type="bibr" rid="B110">110</xref>] and of histone deacetylase (HDAC) [<xref ref-type="bibr" rid="B111">111</xref>] activities. As an inhibitor of GSK3<italic>β</italic>, VPA induces the stabilization of <italic>β</italic>-catenin and the activation of Wnt target genes, though the exact mechanism of GSK3<italic>β</italic> is not currently understood. Indeed,<italic> in utero</italic> exposure to VPA increases the incidence of autism in the offspring [<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B113">113</xref>] and mice models, which have been prenatally exposed to VPA exhibiting ASD-like behaviors and morphological brain abnormalities [<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B114">114</xref>]. Currently, mice prenatally exposed to VPA (VPA mice) are widely used as animal models to understand the onset/development of ASDs [<xref ref-type="bibr" rid="B115">115</xref>]. This VPA mouse model results from intraperitoneal injection in embryonic stages E12–E17, which is a critical period in forebrain development, where dysregulation of Wnt signaling (different time points) induces morphological abnormalities in the brain [<xref ref-type="bibr" rid="B116">116</xref>].</p>
<p>While several molecular mechanisms regarding the onset of ASDs in VPA mice have been reported, the activation of Wnt/<italic>β</italic>-catenin signaling is central through the regulation of GSK3<italic>β</italic>. VPA mice exhibit elevated NMDA receptor levels and enhanced LTP [<xref ref-type="bibr" rid="B117">117</xref>] and inhibition of GABA transporter VGAT expression in cortical cultures [<xref ref-type="bibr" rid="B118">118</xref>], suggesting an important enhancement in excitatory neurotransmission. Likewise, VPA mice induce demethylation of<italic> WNT1</italic> and<italic> WNT2</italic> genes further enhancing Wnt/<italic>β</italic>-catenin signaling [<xref ref-type="bibr" rid="B119">119</xref>]. In this regard, sulindac treatment, an anti-inflammatory drug that downregulates Wnt/<italic>β</italic>-catenin signaling by enhancing GSK3<italic>β</italic> expression in the prefrontal cortex or the hippocampal region of VPA mice [<xref ref-type="bibr" rid="B120">120</xref>], improved repetitive stereotypic activity, learning and memory, as well as behavioral abnormalities [<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>]. Interestingly, the VPA transcriptome revealed enhanced expression of multiple genes involved in Wnt/<italic>β</italic>-catenin, neurotrophin, and LTP signaling, the same pathways which also appear enriched in the transcriptome of lithium [<xref ref-type="bibr" rid="B122">122</xref>], which mimics Wnt/<italic>β</italic>-catenin signaling by inhibiting GSK3<italic>β</italic> [<xref ref-type="bibr" rid="B123">123</xref>]. Nonetheless, although prenatal treatment with VPA appears to enhance the expression of Wnt/<italic>β</italic>-catenin signaling, most of the data comes from<italic> in vitro </italic>cell cultures exposed to VPA and not from<italic> in vivo</italic> studies using mice prenatally exposed to the drug. In this context, it is interesting to note that chronic VPA treatment in mice has been shown to correct dendritic spine deficits and to improve novel object recognition [<xref ref-type="bibr" rid="B124">124</xref>]; thus, the postnatal basal activity of the Wnt/<italic>β</italic>-catenin pathway is still unknown. In this context, it is interesting to note that ASD could result from a transient gain of function of the Wnt/<italic>β</italic>-catenin pathway during embryonic development and a subsequent decline after birth.</p>
<p>Lithium has been widely used to manage mood disorders, such as bipolar disorders, and it is not uncommon for ASD children to feature symptoms within this spectrum such as euphoria, mania, or paranoia [<xref ref-type="bibr" rid="B125">125</xref>]. Few studies have documented the effects of lithium in ASDs but overall they show promising results as a therapeutic agent. For instance, lithium administration to 30 children and adolescents diagnosed with ASD through DSM-IV-TR criteria improved the symptomatology on 43% of patients [<xref ref-type="bibr" rid="B125">125</xref>]. Likewise, chronic administration of lithium to neonatal rats who exhibit ASD-like behaviors abolished their symptoms and improved defects in neurogenesis and E/I balance [<xref ref-type="bibr" rid="B126">126</xref>]. Additionally, chronic lithium treatment reversed the increase in cerebral protein synthesis and ameliorates behavioral abnormalities commonly observed in FXS mice models [<xref ref-type="bibr" rid="B127">127</xref>], probably through inhibitory GSK3<italic>β</italic> phosphorylation (phosphor-Ser9 and phosphor-Ser21) [<xref ref-type="bibr" rid="B128">128</xref>]. Interestingly, pharmacological inhibition of GSK3<italic>β</italic> rescues LTP and hippocampal neurogenesis defects in FMR1 knockout mice and improves cognitive tasks [<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B103">103</xref>]. Furthermore, GSK3<italic>β</italic> inhibition similarly rescues dendritic spines deficit observed in FXS mice suggesting that inhibition of this kinase and thus activation the Wnt/<italic>β</italic>-catenin play a role in reactivating synaptic plasticity and these effects might play an important role in the behavioral and learning improvements observed.</p>
<p>Antagonists for metabotropic glutamate receptor (mGluRs) are up to date the most successful pharmacological modulators improving ASD symptomatology probably through regulation of abnormal mRNA translation at synapses [<xref ref-type="bibr" rid="B129">129</xref>]. In this context, the use of MPEP (2-methyl-6-phenylethynyl-pyridine), mGluR5 antagonists, increases inhibitory GSK3<italic>β</italic> phosphorylation selectively in<italic> FMR1</italic> knockout mice [<xref ref-type="bibr" rid="B130">130</xref>], effect that is mimicked by chronic lithium treatment. Moreover, this compound corrects dendritic spine deficits through upregulation of PSD-95 and learning impairment in FXS mice model [<xref ref-type="bibr" rid="B131">131</xref>], further ascribing a regulatory function directly at the synapses as the underlying mechanism for the therapeutic effect. Finally, MPEP treatment induces the expression of several pathways, including those governed by Wnt signaling in the frontal cortex of rats [<xref ref-type="bibr" rid="B132">132</xref>].</p>
</sec>
<sec id="sec7">
<title>7. Concluding Remarks</title>
<p>ASD displays a high genetic heterogeneity that results in a wide range of abnormal phenotypes and settling a unified paradigm that accounts for the gain or loss of function of genetically associated genes has been an elusive task. Currently, most elements associated with ASDs converge in signaling pathways important for synaptic plasticity, where Wnt/<italic>β</italic>-catenin signaling plays a central role. As described in this review, several lines of evidence indicate that Wnt signaling regulation of serine/threonine kinase GSK3<italic>β</italic> has profound effects in activity dependent synaptic plasticity and thus in the regulation of the E/I balance. Through dissecting Wnt/GSK3<italic>β</italic> activity and pharmacology in cells and animal models of ASDs, it seems plausible that there may be differential effects driven by Wnt/<italic>β</italic>-catenin signaling activity during the initial patterning of brain structures and later on when these structures have been established. Overall, the therapeutic value of GSK3<italic>β</italic> modulation that seems to rescue synaptic plasticity events that could be disrupted in ASD brains warrants further basic and clinical investigation.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgment</title>
<p>This work was supported by FONDECYT Regular 1140353 to Giancarlo V. De Ferrari.</p>
</ack>
<sec sec-type="conflict">
<title>Conflict of Interests</title>
<p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p>
</sec>
<sec>
<title>Authors' Contribution</title>
<p>Mario O. Caracci and Miguel E. Ávila contributed equally to this work.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newschaffer</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Daniels</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The epidemiology of autism spectrum disorders</article-title>
<source/>
<italic>Annual Review of Public Health</italic>
<year>2007</year>
<volume>28</volume>
<fpage>235</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.publhealth.28.021406.144007</pub-id>
<pub-id pub-id-type="other">2-s2.0-34249735268</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeste</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D. H.</given-names>
</name>
</person-group>
<article-title>Disentangling the heterogeneity of autism spectrum disorder through genetic findings</article-title>
<source/>
<italic>Nature Reviews Neurology</italic>
<year>2014</year>
<volume>10</volume>
<issue>2</issue>
<fpage>74</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2013.278</pub-id>
<pub-id pub-id-type="other">2-s2.0-84893844183</pub-id>
<pub-id pub-id-type="pmid">24468882</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenberg</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Yenokyan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McGready</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>P. A.</given-names>
</name>
</person-group>
<article-title>Characteristics and concordance of autism spectrum disorders among 277 twin pairs</article-title>
<source/>
<italic>Archives of Pediatrics &amp; Adolescent Medicine</italic>
<year>2009</year>
<volume>163</volume>
<issue>10</issue>
<fpage>907</fpage>
<lpage>914</lpage>
<pub-id pub-id-type="doi">10.1001/archpediatrics.2009.98</pub-id>
<pub-id pub-id-type="other">2-s2.0-70349753233</pub-id>
<pub-id pub-id-type="pmid">19805709</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betancur</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting</article-title>
<source/>
<italic>Brain Research</italic>
<year>2011</year>
<volume>1380</volume>
<fpage>42</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.078</pub-id>
<pub-id pub-id-type="other">2-s2.0-79952313620</pub-id>
<pub-id pub-id-type="pmid">21129364</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahams</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D. H.</given-names>
</name>
</person-group>
<article-title>Advances in autism genetics: on the threshold of a new neurobiology</article-title>
<source/>
<italic>Nature Reviews Genetics</italic>
<year>2008</year>
<volume>9</volume>
<issue>5</issue>
<fpage>341</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2346</pub-id>
<pub-id pub-id-type="other">2-s2.0-42349095075</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>E. E.</given-names>
</name>
</person-group>
<article-title>A de novo convergence of autism genetics and molecular neuroscience</article-title>
<source/>
<italic>Trends in Neurosciences</italic>
<year>2014</year>
<volume>37</volume>
<issue>2</issue>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.11.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-84893708713</pub-id>
<pub-id pub-id-type="pmid">24387789</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anney</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Individual common variants exert weak effects on the risk for autism spectrum disorders</article-title>
<source/>
<italic>Human Molecular Genetics</italic>
<year>2012</year>
<volume>21</volume>
<issue>21</issue>
<fpage>4781</fpage>
<lpage>4792</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds301</pub-id>
<pub-id pub-id-type="pmid">22843504</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamrom</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare de novo and transmitted copy-number variation in autistic spectrum disorders</article-title>
<source/>
<italic>Neuron</italic>
<year>2011</year>
<volume>70</volume>
<issue>5</issue>
<fpage>886</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.015</pub-id>
<pub-id pub-id-type="other">2-s2.0-79958032110</pub-id>
<pub-id pub-id-type="pmid">21658582</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Ercan-Sencicek</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Hus</surname>
<given-names>V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism</article-title>
<source/>
<italic>Neuron</italic>
<year>2011</year>
<volume>70</volume>
<issue>5</issue>
<fpage>863</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-79958074870</pub-id>
<pub-id pub-id-type="pmid">21658581</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>
<italic>Nature</italic>
<year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="other">2-s2.0-84912101541</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>A. R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>
<source/>
<italic>Nature</italic>
<year>2012</year>
<volume>485</volume>
<issue>7397</issue>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1038/nature10945</pub-id>
<pub-id pub-id-type="other">2-s2.0-84860780495</pub-id>
<pub-id pub-id-type="pmid">22495306</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hormozdiari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Penn</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Borenstein</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>E. E.</given-names>
</name>
</person-group>
<article-title>The discovery of integrated gene networks for autism and related disorders</article-title>
<source/>
<italic>Genome Research</italic>
<year>2015</year>
<volume>25</volume>
<issue>1</issue>
<fpage>142</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1101/gr.178855.114</pub-id>
<pub-id pub-id-type="other">2-s2.0-84920655404</pub-id>
<pub-id pub-id-type="pmid">25378250</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>
<source/>
<italic>Nature</italic>
<year>2012</year>
<volume>484</volume>
<issue>7397</issue>
<fpage>246</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="other">2-s2.0-84860741138</pub-id>
<pub-id pub-id-type="pmid">22437503</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>
<source/>
<italic>Science</italic>
<year>2012</year>
<volume>338</volume>
<issue>6114</issue>
<fpage>1619</fpage>
<lpage>1622</lpage>
<pub-id pub-id-type="doi">10.1126/science.1227764</pub-id>
<pub-id pub-id-type="other">2-s2.0-84871448593</pub-id>
<pub-id pub-id-type="pmid">23160955</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>A. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>
<italic>Nature</italic>
<year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ferrari</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>R. T.</given-names>
</name>
</person-group>
<article-title>The ups and downs of Wnt signaling in prevalent neurological disorders</article-title>
<source/>
<italic>Oncogene</italic>
<year>2006</year>
<volume>25</volume>
<issue>57</issue>
<fpage>7545</fpage>
<lpage>7553</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1210064</pub-id>
<pub-id pub-id-type="other">2-s2.0-33845350346</pub-id>
<pub-id pub-id-type="pmid">17143299</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okerlund</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>B. N. R.</given-names>
</name>
</person-group>
<article-title>Synaptic Wnt signaling—a contributor to major psychiatric disorders?</article-title>
<source/>
<italic>Journal of Neurodevelopmental Disorders</italic>
<year>2011</year>
<volume>3</volume>
<issue>2</issue>
<fpage>162</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-011-9083-6</pub-id>
<pub-id pub-id-type="other">2-s2.0-79958199264</pub-id>
<pub-id pub-id-type="pmid">21533542</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalkman</surname>
<given-names>H. O.</given-names>
</name>
</person-group>
<article-title>A review of the evidence for the canonical Wnt pathway in autism spectrum disorders</article-title>
<source/>
<italic>Molecular Autism</italic>
<year>2012</year>
<volume>3</volume>
<issue>1, article 10</issue>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-10</pub-id>
<pub-id pub-id-type="other">2-s2.0-84868616944</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Kohn</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>De Ferrari</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Kaykas</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>WNT and <italic>β</italic>-catenin signalling: diseases and therapies</article-title>
<source/>
<italic>Nature Reviews Genetics</italic>
<year>2004</year>
<volume>5</volume>
<issue>9</issue>
<fpage>691</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1038/nrg1427</pub-id>
<pub-id pub-id-type="other">2-s2.0-4344584730</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Semenov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tamai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>LDL receptor-related proteins 5 and 6 in Wnt/<italic>β</italic>-catenin signaling: Arrows point the way</article-title>
<source/>
<italic>Development</italic>
<year>2004</year>
<volume>131</volume>
<issue>8</issue>
<fpage>1663</fpage>
<lpage>1677</lpage>
<pub-id pub-id-type="doi">10.1242/dev.01117</pub-id>
<pub-id pub-id-type="other">2-s2.0-2342430345</pub-id>
<pub-id pub-id-type="pmid">15084453</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipina</surname>
<given-names>T. V.</given-names>
</name>
<name>
<surname>Kaidanovich-Beilin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3</article-title>
<source/>
<italic>Synapse</italic>
<year>2011</year>
<volume>65</volume>
<issue>3</issue>
<fpage>234</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1002/syn.20839</pub-id>
<pub-id pub-id-type="other">2-s2.0-78650657649</pub-id>
<pub-id pub-id-type="pmid">20687111</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hart</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>De Los Santos</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>I. N.</given-names>
</name>
<name>
<surname>Rubinfeld</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Polakis</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Downregulation of <italic>β</italic>-catenin by human Axin and its association with the APC tumor suppressor, <italic>β</italic>-catenin and GSK3<italic>β</italic>
</article-title>
<source/>
<italic>Current Biology</italic>
<year>1998</year>
<volume>8</volume>
<issue>10</issue>
<fpage>573</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="doi">10.1016/s0960-9822(98)70226-x</pub-id>
<pub-id pub-id-type="other">2-s2.0-0032492954</pub-id>
<pub-id pub-id-type="pmid">9601641</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clevers</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Wnt/<italic>β</italic>-catenin signaling and disease</article-title>
<source/>
<italic>Cell</italic>
<year>2012</year>
<volume>149</volume>
<issue>6</issue>
<fpage>1192</fpage>
<lpage>1205</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.05.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-84861986053</pub-id>
<pub-id pub-id-type="pmid">22682243</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aberle</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stappert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kispert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kemler</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>
<italic>β</italic>-catenin is a target for the ubiquitin-proteasome pathway</article-title>
<source/>
<italic>The EMBO Journal</italic>
<year>1997</year>
<volume>16</volume>
<issue>13</issue>
<fpage>3797</fpage>
<lpage>3804</lpage>
<pub-id pub-id-type="doi">10.1093/emboj/16.13.3797</pub-id>
<pub-id pub-id-type="other">2-s2.0-0030978351</pub-id>
<pub-id pub-id-type="pmid">9233789</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mak</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Takemaru</surname>
<given-names>K.-I.</given-names>
</name>
<name>
<surname>Kenerson</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>The tuberin-hamartin complex negatively regulates <italic>β</italic>-catenin signaling activity</article-title>
<source/>
<italic>The Journal of Biological Chemistry</italic>
<year>2003</year>
<volume>278</volume>
<issue>8</issue>
<fpage>5947</fpage>
<lpage>5951</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.c200473200</pub-id>
<pub-id pub-id-type="other">2-s2.0-0037458733</pub-id>
<pub-id pub-id-type="pmid">12511557</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mak</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Kenerson</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Aicher</surname>
<given-names>L. D.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>Aberrant <italic>β</italic>-catenin signaling in tuberous sclerosis</article-title>
<source/>
<italic>The American Journal of Pathology</italic>
<year>2005</year>
<volume>167</volume>
<issue>1</issue>
<fpage>107</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/s0002-9440(10)62958-6</pub-id>
<pub-id pub-id-type="other">2-s2.0-21244477860</pub-id>
<pub-id pub-id-type="pmid">15972957</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wassink</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vieland</surname>
<given-names>V. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence supporting WNT2 as an autism susceptibility gene</article-title>
<source/>
<italic>American Journal of Medical Genetics</italic>
<year>2001</year>
<volume>105</volume>
<issue>5</issue>
<fpage>406</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1401</pub-id>
<pub-id pub-id-type="other">2-s2.0-0035827826</pub-id>
<pub-id pub-id-type="pmid">11449391</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boon</surname>
<given-names>E. M. J.</given-names>
</name>
<name>
<surname>Van der Neut</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van de Wetering</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pals</surname>
<given-names>S. T.</given-names>
</name>
</person-group>
<article-title>Wnt signaling regulates expression of the receptor tyrosine kinase Met in colorectal cancer</article-title>
<source/>
<italic>Cancer Research</italic>
<year>2002</year>
<volume>62</volume>
<issue>18</issue>
<fpage>5126</fpage>
<lpage>5128</lpage>
<pub-id pub-id-type="other">2-s2.0-0037105707</pub-id>
<pub-id pub-id-type="pmid">12234972</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuynman</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>E. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer</article-title>
<source/>
<italic>Cancer Research</italic>
<year>2008</year>
<volume>68</volume>
<issue>4</issue>
<fpage>1213</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.can-07-5172</pub-id>
<pub-id pub-id-type="other">2-s2.0-39449084394</pub-id>
<pub-id pub-id-type="pmid">18281498</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>P. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A genetic variant that disrupts MET transcription is associated with autism</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2006</year>
<volume>103</volume>
<issue>45</issue>
<fpage>16834</fpage>
<lpage>16839</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0605296103</pub-id>
<pub-id pub-id-type="other">2-s2.0-33750962208</pub-id>
<pub-id pub-id-type="pmid">17053076</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redies</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hertel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hübner</surname>
<given-names>C. A.</given-names>
</name>
</person-group>
<article-title>Cadherins and neuropsychiatric disorders</article-title>
<source/>
<italic>Brain Research</italic>
<year>2012</year>
<volume>1470</volume>
<fpage>130</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2012.06.020</pub-id>
<pub-id pub-id-type="other">2-s2.0-84864584881</pub-id>
<pub-id pub-id-type="pmid">22765916</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Roak</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Deriziotis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations</article-title>
<source/>
<italic>Nature Genetics</italic>
<year>2011</year>
<volume>43</volume>
<issue>6</issue>
<fpage>585</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1038/ng.835</pub-id>
<pub-id pub-id-type="other">2-s2.0-79957589237</pub-id>
<pub-id pub-id-type="pmid">21572417</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bochar</surname>
<given-names>D. A.</given-names>
</name>
</person-group>
<article-title>CHD8 is an ATP-dependent chromatin remodeling factor that regulates <italic>β</italic>-catenin target genes</article-title>
<source/>
<italic>Molecular and Cellular Biology</italic>
<year>2008</year>
<volume>28</volume>
<issue>12</issue>
<fpage>3894</fpage>
<lpage>3904</lpage>
<pub-id pub-id-type="doi">10.1128/mcb.00322-08</pub-id>
<pub-id pub-id-type="other">2-s2.0-44949144048</pub-id>
<pub-id pub-id-type="pmid">18378692</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.-I.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin–Kaiso trajectory of the Wnt signaling pathway</article-title>
<source/>
<italic>Journal of Cell Science</italic>
<year>2012</year>
<volume>125</volume>
<issue>3</issue>
<fpage>561</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.086173</pub-id>
<pub-id pub-id-type="other">2-s2.0-84863292131</pub-id>
<pub-id pub-id-type="pmid">22389395</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courchesne</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>C. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping early brain development in autism</article-title>
<source/>
<italic>Neuron</italic>
<year>2007</year>
<volume>56</volume>
<issue>2</issue>
<fpage>399</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.016</pub-id>
<pub-id pub-id-type="other">2-s2.0-50849130596</pub-id>
<pub-id pub-id-type="pmid">17964254</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Ligt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Van Bon</surname>
<given-names>B. W. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>
<source/>
<italic>The New England Journal of Medicine</italic>
<year>2012</year>
<volume>367</volume>
<issue>20</issue>
<fpage>1921</fpage>
<lpage>1929</lpage>
<pub-id pub-id-type="doi">10.1056/nejmoa1206524</pub-id>
<pub-id pub-id-type="other">2-s2.0-84868686559</pub-id>
<pub-id pub-id-type="pmid">23033978</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubenstein</surname>
<given-names>J. L. R.</given-names>
</name>
</person-group>
<article-title>Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder</article-title>
<source/>
<italic>Current Opinion in Neurology</italic>
<year>2010</year>
<volume>23</volume>
<issue>2</issue>
<fpage>118</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1097/wco.0b013e328336eb13</pub-id>
<pub-id pub-id-type="other">2-s2.0-77949418629</pub-id>
<pub-id pub-id-type="pmid">20087182</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vattikuti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>C. C.</given-names>
</name>
</person-group>
<article-title>A computational model for cerebral cortical dysfunction in autism spectrum disorders</article-title>
<source/>
<italic>Biological Psychiatry</italic>
<year>2010</year>
<volume>67</volume>
<issue>7</issue>
<fpage>672</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-77949492770</pub-id>
<pub-id pub-id-type="pmid">19880095</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yizhar</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fenno</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Prigge</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neocortical excitation/inhibition balance in information processing and social dysfunction</article-title>
<source/>
<italic>Nature</italic>
<year>2011</year>
<volume>477</volume>
<issue>7363</issue>
<fpage>171</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1038/nature10360</pub-id>
<pub-id pub-id-type="other">2-s2.0-80052563319</pub-id>
<pub-id pub-id-type="pmid">21796121</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</name>
</person-group>
<article-title>Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities</article-title>
<source/>
<italic>Cold Spring Harbor Perspectives in Biology</italic>
<year>2012</year>
<volume>4</volume>
<issue>3</issue>
<pub-id pub-id-type="publisher-id">a009886</pub-id>
<pub-id pub-id-type="doi">10.1101/cshperspect.a009886</pub-id>
<pub-id pub-id-type="other">2-s2.0-84862659562</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuchman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rapin</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Epilepsy in autism</article-title>
<source/>
<italic>The Lancet Neurology</italic>
<year>2002</year>
<volume>1</volume>
<issue>6</issue>
<fpage>352</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/s1474-4422(02)00160-6</pub-id>
<pub-id pub-id-type="other">2-s2.0-0041510584</pub-id>
<pub-id pub-id-type="pmid">12849396</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheffer</surname>
<given-names>I. E.</given-names>
</name>
<name>
<surname>Berkovic</surname>
<given-names>S. F.</given-names>
</name>
</person-group>
<article-title>The genetics of human epilepsy</article-title>
<source/>
<italic>Trends in Pharmacological Sciences</italic>
<year>2003</year>
<volume>24</volume>
<issue>8</issue>
<fpage>428</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1016/s0165-6147(03)00194-9</pub-id>
<pub-id pub-id-type="other">2-s2.0-0043162099</pub-id>
<pub-id pub-id-type="pmid">12915053</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staley</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of epilepsy</article-title>
<source/>
<italic>Nature Neuroscience</italic>
<year>2015</year>
<volume>18</volume>
<issue>3</issue>
<fpage>367</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3947</pub-id>
<pub-id pub-id-type="pmid">25710839</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ferrari and</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>N. C.</given-names>
</name>
</person-group>
<article-title>Wnt signaling function in Alzheimer's disease</article-title>
<source/>
<italic>Brain Research Reviews</italic>
<year>2000</year>
<volume>33</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0173(00)00021-7</pub-id>
<pub-id pub-id-type="other">2-s2.0-0033850796</pub-id>
<pub-id pub-id-type="pmid">10967351</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad-Annuar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ciani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Simeonidis</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release</article-title>
<source/>
<italic>Journal of Cell Biology</italic>
<year>2006</year>
<volume>174</volume>
<issue>1</issue>
<fpage>127</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200511054</pub-id>
<pub-id pub-id-type="other">2-s2.0-33745606159</pub-id>
<pub-id pub-id-type="pmid">16818724</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inestrosa</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Arenas</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Emerging roles of Wnts in the adult nervous system</article-title>
<source/>
<italic>Nature Reviews Neuroscience</italic>
<year>2010</year>
<volume>11</volume>
<issue>2</issue>
<fpage>77</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2755</pub-id>
<pub-id pub-id-type="other">2-s2.0-75549087261</pub-id>
<pub-id pub-id-type="pmid">20010950</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Dickins</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca<sup>2+</sup>/Calmodulin-dependent protein kinase II</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences</italic>
<year>2011</year>
<volume>108</volume>
<issue>26</issue>
<fpage>10732</fpage>
<lpage>10737</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1018132108</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ferrari</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Pérez-Palma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bustos</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Alarcón</surname>
<given-names>M. A.</given-names>
</name>
</person-group>
<article-title>Wnt/<italic>β</italic>-catenin signaling in Alzheimer's disease</article-title>
<source/>
<italic>CNS and Neurological Disorders—Drug Targets</italic>
<year>2014</year>
<volume>13</volume>
<issue>5</issue>
<fpage>745</fpage>
<lpage>754</lpage>
<pub-id pub-id-type="doi">10.2174/1871527312666131223113900</pub-id>
<pub-id pub-id-type="other">2-s2.0-84905591087</pub-id>
<pub-id pub-id-type="pmid">24365184</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itasaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Mercurio</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wise, a context-dependent activator and inhibitor of Wnt signalling</article-title>
<source/>
<italic>Development</italic>
<year>2003</year>
<volume>130</volume>
<issue>18</issue>
<fpage>4295</fpage>
<lpage>4305</lpage>
<pub-id pub-id-type="doi">10.1242/dev.00674</pub-id>
<pub-id pub-id-type="other">2-s2.0-0141725483</pub-id>
<pub-id pub-id-type="pmid">12900447</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ettenberg</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Charlat</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Daley</surname>
<given-names>M. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2010</year>
<volume>107</volume>
<issue>35</issue>
<fpage>15473</fpage>
<lpage>15478</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1007428107</pub-id>
<pub-id pub-id-type="other">2-s2.0-77957266335</pub-id>
<pub-id pub-id-type="pmid">20713706</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caricasole</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iacovelli</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional characterization of WNT7A signaling in PC12 cells: interaction with a FZD5·LRP6 receptor complex and modulation by Dickkopf proteins</article-title>
<source/>
<italic>The Journal of Biological Chemistry</italic>
<year>2003</year>
<volume>278</volume>
<issue>39</issue>
<fpage>37024</fpage>
<lpage>37031</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m300191200</pub-id>
<pub-id pub-id-type="pmid">12857724</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-throughput genetic screen for synaptogenic factors: identification of LRP6 as critical for excitatory synapse development</article-title>
<source/>
<italic>Cell Reports</italic>
<year>2013</year>
<volume>5</volume>
<issue>5</issue>
<fpage>1330</fpage>
<lpage>1341</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2013.11.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-84890229121</pub-id>
<pub-id pub-id-type="pmid">24316074</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>S.-J.</given-names>
</name>
</person-group>
<article-title>Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation</article-title>
<source/>
<italic>The Journal of Biological Chemistry</italic>
<year>2006</year>
<volume>281</volume>
<issue>17</issue>
<fpage>11910</fpage>
<lpage>11916</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m511920200</pub-id>
<pub-id pub-id-type="other">2-s2.0-33744958556</pub-id>
<pub-id pub-id-type="pmid">16501258</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avila</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Sepúlveda</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Burgos</surname>
<given-names>C. F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Canonical Wnt3a modulates intracellular calcium and enhances excitatory neurotransmission in hippocampal neurons</article-title>
<source/>
<italic>The Journal of Biological Chemistry</italic>
<year>2010</year>
<volume>285</volume>
<issue>24</issue>
<fpage>18939</fpage>
<lpage>18947</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m110.103028</pub-id>
<pub-id pub-id-type="other">2-s2.0-77953295258</pub-id>
<pub-id pub-id-type="pmid">20404321</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerpa</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Godoy</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Alfaro</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons</article-title>
<source/>
<italic>The Journal of Biological Chemistry</italic>
<year>2008</year>
<volume>283</volume>
<issue>9</issue>
<fpage>5918</fpage>
<lpage>5927</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m705943200</pub-id>
<pub-id pub-id-type="other">2-s2.0-41949142202</pub-id>
<pub-id pub-id-type="pmid">18096705</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lijam</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>M. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1</article-title>
<source/>
<italic>Cell</italic>
<year>1997</year>
<volume>90</volume>
<issue>5</issue>
<fpage>895</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80354-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-0030866899</pub-id>
<pub-id pub-id-type="pmid">9298901</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cesca</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Baldelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Valtorta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Benfenati</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The synapsins: key actors of synapse function and plasticity</article-title>
<source/>
<italic>Progress in Neurobiology</italic>
<year>2010</year>
<volume>91</volume>
<issue>4</issue>
<fpage>313</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2010.04.006</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954202334</pub-id>
<pub-id pub-id-type="pmid">20438797</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fassio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Patry</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Congia</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function</article-title>
<source/>
<italic>Human Molecular Genetics</italic>
<year>2011</year>
<volume>20</volume>
<issue>12</issue>
<fpage>2297</fpage>
<lpage>2307</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr122</pub-id>
<pub-id pub-id-type="other">2-s2.0-79957456437</pub-id>
<pub-id pub-id-type="pmid">21441247</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corradi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fadda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piton</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SYN2 is an autism predisposing gene: loss-offunction mutations alter synaptic vesicle cycling and axon outgrowth</article-title>
<source/>
<italic>Human Molecular Genetics</italic>
<year>2014</year>
<volume>23</volume>
<issue>1</issue>
<fpage>90</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="publisher-id">ddt401</pub-id>
<pub-id pub-id-type="doi">10.1093/hmg/ddt401</pub-id>
<pub-id pub-id-type="other">2-s2.0-84890350967</pub-id>
<pub-id pub-id-type="pmid">23956174</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greco</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Managò</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tucci</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>H.-T.</given-names>
</name>
<name>
<surname>Valtorta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Benfenati</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Autism-related behavioral abnormalities in synapsin knockout mice</article-title>
<source/>
<italic>Behavioural Brain Research</italic>
<year>2013</year>
<volume>251</volume>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2012.12.015</pub-id>
<pub-id pub-id-type="other">2-s2.0-84880332828</pub-id>
<pub-id pub-id-type="pmid">23280234</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>P. C.</given-names>
</name>
</person-group>
<article-title>Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling</article-title>
<source/>
<italic>Cell</italic>
<year>2000</year>
<volume>100</volume>
<issue>5</issue>
<fpage>525</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1016/s0092-8674(00)80689-3</pub-id>
<pub-id pub-id-type="other">2-s2.0-0034598921</pub-id>
<pub-id pub-id-type="pmid">10721990</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hödar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Assar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Colombres</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide identification of new Wnt/<italic>β</italic>-catenin target genes in the human genome using CART method</article-title>
<source/>
<italic>BMC Genomics</italic>
<year>2010</year>
<volume>11</volume>
<issue>1, article 348</issue>
<pub-id pub-id-type="doi">10.1186/1471-2164-11-348</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954279005</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohn</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pirone</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities</article-title>
<source/>
<italic>Molecular Psychiatry</italic>
<year>2014</year>
<volume>19</volume>
<issue>10</issue>
<fpage>1133</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.61</pub-id>
<pub-id pub-id-type="other">2-s2.0-84902234785</pub-id>
<pub-id pub-id-type="pmid">24934177</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hamao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dvl regulates endo- and exocytotic processes through binding to synaptotagmin</article-title>
<source/>
<italic>Genes to Cells</italic>
<year>2007</year>
<volume>12</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2443.2006.01030.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-33845779415</pub-id>
<pub-id pub-id-type="pmid">17212654</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamji</surname>
<given-names>S. X.</given-names>
</name>
<name>
<surname>Shimazu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kimes</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of beta-catenin in synaptic vesicle localization and presynaptic assembly</article-title>
<source/>
<italic>Neuron</italic>
<year>2003</year>
<volume>40</volume>
<issue>4</issue>
<fpage>719</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="doi">10.1016/s0896-6273(03)00718-9</pub-id>
<pub-id pub-id-type="other">2-s2.0-0242573316</pub-id>
<pub-id pub-id-type="pmid">14622577</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takeichi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Uemura</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>DN-cadherin is required for spatial arrangement of nerve terminals and ultrastructural organization of synapses</article-title>
<source/>
<italic>Molecular and Cellular Neuroscience</italic>
<year>2002</year>
<volume>19</volume>
<issue>3</issue>
<fpage>375</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.2001.1081</pub-id>
<pub-id pub-id-type="other">2-s2.0-0036214528</pub-id>
<pub-id pub-id-type="pmid">11906210</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jüngling</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Eulenburg</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kemler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lessmann</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gottmann</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>N-cadherin transsynaptically regulates short-term plasticity at glutamatergic synapses in embryonic stem cell-derived neurons</article-title>
<source/>
<italic>The Journal of Neuroscience</italic>
<year>2006</year>
<volume>26</volume>
<issue>26</issue>
<fpage>6968</fpage>
<lpage>6978</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.1013-06.2006</pub-id>
<pub-id pub-id-type="other">2-s2.0-33745959647</pub-id>
<pub-id pub-id-type="pmid">16807326</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aiga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Humbert</surname>
<given-names>P. O.</given-names>
</name>
<name>
<surname>Bamji</surname>
<given-names>S. X.</given-names>
</name>
</person-group>
<article-title>Scribble interacts with <italic>β</italic>-catenin to localize synaptic vesicles to synapses</article-title>
<source/>
<italic>Molecular Biology of the Cell</italic>
<year>2009</year>
<volume>20</volume>
<issue>14</issue>
<fpage>3390</fpage>
<lpage>3400</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.e08-12-1172</pub-id>
<pub-id pub-id-type="other">2-s2.0-67749103532</pub-id>
<pub-id pub-id-type="pmid">19458197</pub-id>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Togashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takaoka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chisaka</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Takeichi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cadherin regulates dendritic spine morphogenesis</article-title>
<source/>
<italic>Neuron</italic>
<year>2002</year>
<volume>35</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(02)00748-1</pub-id>
<pub-id pub-id-type="other">2-s2.0-0037014446</pub-id>
<pub-id pub-id-type="pmid">12123610</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamji</surname>
<given-names>S. X.</given-names>
</name>
<name>
<surname>Rico</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kimes</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>L. F.</given-names>
</name>
</person-group>
<article-title>BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-<italic>β</italic>-catenin interactions</article-title>
<source/>
<italic>The Journal of Cell Biology</italic>
<year>2006</year>
<volume>174</volume>
<issue>2</issue>
<fpage>289</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200601087</pub-id>
<pub-id pub-id-type="other">2-s2.0-33746048845</pub-id>
<pub-id pub-id-type="pmid">16831887</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connolly</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>A genome-wide association study of autism incorporating autism diagnostic interview–revised, autism diagnostic observation schedule, and social responsiveness scale</article-title>
<source/>
<italic>Child Development</italic>
<year>2013</year>
<volume>84</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1111/j.1467-8624.2012.01838.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872924220</pub-id>
<pub-id pub-id-type="pmid">22935194</pub-id>
</element-citation>
</ref>
<ref id="B72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>I.-F.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>Y. G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synapses are regulated by the cytoplasmic tyrosine kinase Fer in a pathway mediated by p120catenin, Fer, SHP-2, and <italic>β</italic>-catenin</article-title>
<source/>
<italic>The Journal of Cell Biology</italic>
<year>2008</year>
<volume>183</volume>
<issue>5</issue>
<fpage>893</fpage>
<lpage>908</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200807188</pub-id>
<pub-id pub-id-type="other">2-s2.0-58149288206</pub-id>
<pub-id pub-id-type="pmid">19047464</pub-id>
</element-citation>
</ref>
<ref id="B73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Yeramian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duñach</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential <italic>β</italic>-catenin phosphorylation</article-title>
<source/>
<italic>Journal of Cell Science</italic>
<year>2008</year>
<volume>121</volume>
<issue>16</issue>
<fpage>2718</fpage>
<lpage>2730</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.029660</pub-id>
<pub-id pub-id-type="other">2-s2.0-52649150425</pub-id>
<pub-id pub-id-type="pmid">18664491</pub-id>
</element-citation>
</ref>
<ref id="B74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerpa</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gambrill</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Barria</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Regulation of NMDA-receptor synaptic transmission by Wnt signaling</article-title>
<source/>
<italic>The Journal of Neuroscience</italic>
<year>2011</year>
<volume>31</volume>
<issue>26</issue>
<fpage>9466</fpage>
<lpage>9471</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.6311-10.2011</pub-id>
<pub-id pub-id-type="other">2-s2.0-79959960791</pub-id>
<pub-id pub-id-type="pmid">21715611</pub-id>
</element-citation>
</ref>
<ref id="B75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varela-Nallar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Alfaro</surname>
<given-names>I. E.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>Parodi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>N. C.</given-names>
</name>
</person-group>
<article-title>Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2010</year>
<volume>107</volume>
<issue>49</issue>
<fpage>21164</fpage>
<lpage>21169</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010011107</pub-id>
<pub-id pub-id-type="other">2-s2.0-78650506425</pub-id>
<pub-id pub-id-type="pmid">21084636</pub-id>
</element-citation>
</ref>
<ref id="B76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>M. E.</given-names>
</name>
</person-group>
<article-title>Communication between the synapse and the nucleus in neuronal development, plasticity, and disease</article-title>
<source/>
<italic>Annual Review of Cell and Developmental Biology</italic>
<year>2008</year>
<volume>24</volume>
<fpage>183</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.cellbio.24.110707.175235</pub-id>
<pub-id pub-id-type="other">2-s2.0-55849130994</pub-id>
</element-citation>
</ref>
<ref id="B77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arrázola</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Varela-Nallar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Colombres</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/<italic>β</italic>-catenin signaling pathway</article-title>
<source/>
<italic>Journal of Cellular Physiology</italic>
<year>2009</year>
<volume>221</volume>
<issue>3</issue>
<fpage>658</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.21902</pub-id>
<pub-id pub-id-type="other">2-s2.0-70449699789</pub-id>
<pub-id pub-id-type="pmid">19711354</pub-id>
</element-citation>
</ref>
<ref id="B78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redmond</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kashani</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription</article-title>
<source/>
<italic>Neuron</italic>
<year>2002</year>
<volume>34</volume>
<issue>6</issue>
<fpage>999</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(02)00737-7</pub-id>
<pub-id pub-id-type="other">2-s2.0-0037071893</pub-id>
<pub-id pub-id-type="pmid">12086646</pub-id>
</element-citation>
</ref>
<ref id="B79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waltes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Duketis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders</article-title>
<source/>
<italic>Human Genetics</italic>
<year>2014</year>
<volume>133</volume>
<issue>6</issue>
<fpage>781</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-013-1416-y</pub-id>
<pub-id pub-id-type="other">2-s2.0-84901188282</pub-id>
<pub-id pub-id-type="pmid">24442360</pub-id>
</element-citation>
</ref>
<ref id="B80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>R. C.</given-names>
</name>
</person-group>
<article-title>
<italic>β</italic>-catenin is critical for dendritic morphogenesis</article-title>
<source/>
<italic>Nature Neuroscience</italic>
<year>2003</year>
<volume>6</volume>
<issue>11</issue>
<fpage>1169</fpage>
<lpage>1177</lpage>
<pub-id pub-id-type="doi">10.1038/nn1132</pub-id>
<pub-id pub-id-type="other">2-s2.0-0242384747</pub-id>
<pub-id pub-id-type="pmid">14528308</pub-id>
</element-citation>
</ref>
<ref id="B81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malenka</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M. F.</given-names>
</name>
</person-group>
<article-title>LTP and LTD: an embarrassment of riches</article-title>
<source/>
<italic>Neuron</italic>
<year>2004</year>
<volume>44</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2004.09.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-5344241223</pub-id>
<pub-id pub-id-type="pmid">15450156</pub-id>
</element-citation>
</ref>
<ref id="B82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bemben</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shipman</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CaMKII phosphorylation of neuroligin-1 regulates excitatory synapses</article-title>
<source/>
<italic>Nature Neuroscience</italic>
<year>2014</year>
<volume>17</volume>
<issue>1</issue>
<fpage>56</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3601</pub-id>
<pub-id pub-id-type="other">2-s2.0-84893787911</pub-id>
<pub-id pub-id-type="pmid">24336150</pub-id>
</element-citation>
</ref>
<ref id="B83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>L.-H.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gazit</surname>
<given-names>V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex</article-title>
<source/>
<italic>Neurobiology of Disease</italic>
<year>2007</year>
<volume>28</volume>
<issue>2</issue>
<fpage>184</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2007.07.015</pub-id>
<pub-id pub-id-type="other">2-s2.0-35348950503</pub-id>
<pub-id pub-id-type="pmid">17714952</pub-id>
</element-citation>
</ref>
<ref id="B84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse</article-title>
<source/>
<italic>Human Molecular Genetics</italic>
<year>2011</year>
<volume>20</volume>
<issue>23</issue>
<fpage>4666</fpage>
<lpage>4683</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr400</pub-id>
<pub-id pub-id-type="other">2-s2.0-81255209206</pub-id>
<pub-id pub-id-type="pmid">21903668</pub-id>
</element-citation>
</ref>
<ref id="B85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yun</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Trommer</surname>
<given-names>B. L.</given-names>
</name>
</person-group>
<article-title>Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus</article-title>
<source/>
<italic>Journal of Neuroscience Research</italic>
<year>2011</year>
<volume>89</volume>
<issue>2</issue>
<fpage>176</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22546</pub-id>
<pub-id pub-id-type="other">2-s2.0-78650215787</pub-id>
<pub-id pub-id-type="pmid">21162125</pub-id>
</element-citation>
</ref>
<ref id="B86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chubb</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Bradshaw</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Porteous</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Millar</surname>
<given-names>J. K.</given-names>
</name>
</person-group>
<article-title>The DISC locus in psychiatric illness</article-title>
<source/>
<italic>Molecular Psychiatry</italic>
<year>2008</year>
<volume>13</volume>
<issue>1</issue>
<fpage>36</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4002106</pub-id>
<pub-id pub-id-type="other">2-s2.0-37449007716</pub-id>
<pub-id pub-id-type="pmid">17912248</pub-id>
</element-citation>
</ref>
<ref id="B87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilpinen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ylisaukko-Oja</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hennah</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of DISC1 with autism and Asperger syndrome</article-title>
<source/>
<italic>Molecular Psychiatry</italic>
<year>2008</year>
<volume>13</volume>
<issue>2</issue>
<fpage>187</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4002031</pub-id>
<pub-id pub-id-type="other">2-s2.0-38349191027</pub-id>
<pub-id pub-id-type="pmid">17579608</pub-id>
</element-citation>
</ref>
<ref id="B88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crepel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Breckpot</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>J.-P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DISC1 duplication in two brothers with autism and mild mental retardation</article-title>
<source/>
<italic>Clinical Genetics</italic>
<year>2010</year>
<volume>77</volume>
<issue>4</issue>
<fpage>389</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2009.01318.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-77951747865</pub-id>
<pub-id pub-id-type="pmid">20002455</pub-id>
</element-citation>
</ref>
<ref id="B89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>De Rienzo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Drane</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common DISC1 polymorphisms disrupt Wnt/GSK3<italic>β</italic> signaling and brain development</article-title>
<source/>
<italic>Neuron</italic>
<year>2011</year>
<volume>72</volume>
<issue>4</issue>
<fpage>545</fpage>
<lpage>558</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.030</pub-id>
<pub-id pub-id-type="other">2-s2.0-81355150792</pub-id>
<pub-id pub-id-type="pmid">22099458</pub-id>
</element-citation>
</ref>
<ref id="B90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boucher</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mayes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bigham</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Memory in autistic spectrum disorder</article-title>
<source/>
<italic>Psychological Bulletin</italic>
<year>2012</year>
<volume>138</volume>
<issue>3</issue>
<fpage>458</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1037/a0026869</pub-id>
<pub-id pub-id-type="other">2-s2.0-84864517212</pub-id>
<pub-id pub-id-type="pmid">22409507</pub-id>
</element-citation>
</ref>
<ref id="B91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowler</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Gaigg</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Gardiner</surname>
<given-names>J. M.</given-names>
</name>
</person-group>
<article-title>Binding of multiple features in memory by high-functioning adults with autism spectrum disorder</article-title>
<source/>
<italic>Journal of Autism and Developmental Disorders</italic>
<year>2014</year>
<volume>44</volume>
<issue>9</issue>
<fpage>2355</fpage>
<lpage>2362</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-014-2105-y</pub-id>
<pub-id pub-id-type="other">2-s2.0-84906324296</pub-id>
<pub-id pub-id-type="pmid">24696375</pub-id>
</element-citation>
</ref>
<ref id="B92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hur</surname>
<given-names>E.-M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F.-Q.</given-names>
</name>
</person-group>
<article-title>GSK3 signalling in neural development</article-title>
<source/>
<italic>Nature Reviews Neuroscience</italic>
<year>2010</year>
<volume>11</volume>
<issue>8</issue>
<fpage>539</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2870</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954874401</pub-id>
<pub-id pub-id-type="pmid">20648061</pub-id>
</element-citation>
</ref>
<ref id="B93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benedetti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bernasconi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lorenzi</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A single nucleotide polymorphism in glycogen synthase kinase 3-<italic>β</italic> promoter gene influences onset of illness in patients affected by bipolar disorder</article-title>
<source/>
<italic>Neuroscience Letters</italic>
<year>2004</year>
<volume>355</volume>
<issue>1-2</issue>
<fpage>37</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2003.10.021</pub-id>
<pub-id pub-id-type="other">2-s2.0-0346023025</pub-id>
<pub-id pub-id-type="pmid">14729229</pub-id>
</element-citation>
</ref>
<ref id="B94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooper</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Killick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lovestone</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The GSK3 hypothesis of Alzheimer's disease</article-title>
<source/>
<italic>Journal of Neurochemistry</italic>
<year>2008</year>
<volume>104</volume>
<issue>6</issue>
<fpage>1433</fpage>
<lpage>1439</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.05194.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-39849110726</pub-id>
<pub-id pub-id-type="pmid">18088381</pub-id>
</element-citation>
</ref>
<ref id="B95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Romano-Silva</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A. H. C.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>J. L.</given-names>
</name>
</person-group>
<article-title>Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response</article-title>
<source/>
<italic>Psychopharmacology</italic>
<year>2008</year>
<volume>200</volume>
<issue>2</issue>
<fpage>177</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-008-1193-9</pub-id>
<pub-id pub-id-type="other">2-s2.0-51249097728</pub-id>
<pub-id pub-id-type="pmid">18500637</pub-id>
</element-citation>
</ref>
<ref id="B96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>C. L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling</article-title>
<source/>
<italic>Cell</italic>
<year>2009</year>
<volume>136</volume>
<issue>6</issue>
<fpage>1017</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.12.044</pub-id>
<pub-id pub-id-type="other">2-s2.0-62149083806</pub-id>
<pub-id pub-id-type="pmid">19303846</pub-id>
</element-citation>
</ref>
<ref id="B97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of GSK3<italic>β</italic> improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome</article-title>
<source/>
<italic>Human Molecular Genetics</italic>
<year>2012</year>
<volume>21</volume>
<issue>3</issue>
<fpage>681</fpage>
<lpage>691</lpage>
<pub-id pub-id-type="publisher-id">ddr501</pub-id>
<pub-id pub-id-type="doi">10.1093/hmg/ddr501</pub-id>
<pub-id pub-id-type="other">2-s2.0-84862908964</pub-id>
<pub-id pub-id-type="pmid">22048960</pub-id>
</element-citation>
</ref>
<ref id="B98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fragile X mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells</article-title>
<source/>
<italic>PLoS Genetics</italic>
<year>2010</year>
<volume>6</volume>
<issue>4</issue>
<pub-id pub-id-type="publisher-id">e1000898</pub-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000898</pub-id>
<pub-id pub-id-type="other">2-s2.0-77952353946</pub-id>
</element-citation>
</ref>
<ref id="B99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mines</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Yuskaitis</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Beurel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism</article-title>
<source/>
<italic>PLoS ONE</italic>
<year>2010</year>
<volume>5</volume>
<issue>3</issue>
<pub-id pub-id-type="publisher-id">e9706</pub-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0009706</pub-id>
<pub-id pub-id-type="other">2-s2.0-77956650465</pub-id>
</element-citation>
</ref>
<ref id="B100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comery</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>P. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>1997</year>
<volume>94</volume>
<issue>10</issue>
<fpage>5401</fpage>
<lpage>5404</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.10.5401</pub-id>
<pub-id pub-id-type="other">2-s2.0-0030986183</pub-id>
<pub-id pub-id-type="pmid">9144249</pub-id>
</element-citation>
</ref>
<ref id="B101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peça</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>J. T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>
<source/>
<italic>Nature</italic>
<year>2011</year>
<volume>472</volume>
<issue>7344</issue>
<fpage>437</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1038/nature09965</pub-id>
<pub-id pub-id-type="other">2-s2.0-79955536349</pub-id>
<pub-id pub-id-type="pmid">21423165</pub-id>
</element-citation>
</ref>
<ref id="B102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dindot</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Antalffy</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Bhattacharjee</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>A. L.</given-names>
</name>
</person-group>
<article-title>The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology</article-title>
<source/>
<italic>Human Molecular Genetics</italic>
<year>2008</year>
<volume>17</volume>
<issue>1</issue>
<fpage>111</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddm288</pub-id>
<pub-id pub-id-type="other">2-s2.0-37549057995</pub-id>
<pub-id pub-id-type="pmid">17940072</pub-id>
</element-citation>
</ref>
<ref id="B103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latapy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rioux</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Guitton</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Beaulieu</surname>
<given-names>J.-M.</given-names>
</name>
</person-group>
<article-title>Selective deletion of forebrain glycogen synthase kinase 3<italic>β</italic> reveals a central role in serotonin-sensitive anxiety and social behaviour</article-title>
<source/>
<italic>Philosophical Transactions of the Royal Society B: Biological Sciences</italic>
<year>2012</year>
<volume>367</volume>
<issue>1601</issue>
<fpage>2460</fpage>
<lpage>2474</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2012.0094</pub-id>
<pub-id pub-id-type="other">2-s2.0-84864198258</pub-id>
</element-citation>
</ref>
<ref id="B104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernández</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Borrell</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guaza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>J. J.</given-names>
</name>
</person-group>
<article-title>Spatial learning deficit in transgenic mice that conditionally over-express GSK-3<italic>β</italic> in the brain but do not form tau filaments</article-title>
<source/>
<italic>Journal of Neurochemistry</italic>
<year>2002</year>
<volume>83</volume>
<issue>6</issue>
<fpage>1529</fpage>
<lpage>1533</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.2002.01269.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-1642363745</pub-id>
<pub-id pub-id-type="pmid">12472906</pub-id>
</element-citation>
</ref>
<ref id="B105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochs</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Dorostkar</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Aramuni</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of neuronal GSK3<italic>β</italic> reduces dendritic spine stability and attenuates excitatory synaptic transmission via <italic>β</italic>-catenin</article-title>
<source/>
<italic>Molecular Psychiatry</italic>
<year>2014</year>
<pub-id pub-id-type="doi">10.1038/mp.2014.55</pub-id>
<pub-id pub-id-type="other">2-s2.0-84901903183</pub-id>
</element-citation>
</ref>
<ref id="B106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Glycogen synthase kinase 3 regulates N-methyl-D-aspartate receptor channel trafficking and function in cortical neurons</article-title>
<source/>
<italic>Molecular Pharmacology</italic>
<year>2007</year>
<volume>72</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1124/mol.107.034942</pub-id>
<pub-id pub-id-type="other">2-s2.0-34347218580</pub-id>
<pub-id pub-id-type="pmid">17400762</pub-id>
</element-citation>
</ref>
<ref id="B107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L.-Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments</article-title>
<source/>
<italic>The Journal of Neuroscience</italic>
<year>2007</year>
<volume>27</volume>
<issue>45</issue>
<fpage>12211</fpage>
<lpage>12220</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.3321-07.2007</pub-id>
<pub-id pub-id-type="other">2-s2.0-36048937547</pub-id>
<pub-id pub-id-type="pmid">17989287</pub-id>
</element-citation>
</ref>
<ref id="B108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tzavaras</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tsokas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Blitzer</surname>
<given-names>R. D.</given-names>
</name>
</person-group>
<article-title>Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3</article-title>
<source/>
<italic>The Journal of Neuroscience</italic>
<year>2011</year>
<volume>31</volume>
<issue>48</issue>
<fpage>17537</fpage>
<lpage>17546</lpage>
<pub-id pub-id-type="doi">10.1523/jneurosci.4761-11.2011</pub-id>
<pub-id pub-id-type="other">2-s2.0-82555174660</pub-id>
<pub-id pub-id-type="pmid">22131415</pub-id>
</element-citation>
</ref>
<ref id="B109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verrotti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scaparrotta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cofini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chiarelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tiboni</surname>
<given-names>G. M.</given-names>
</name>
</person-group>
<article-title>Developmental neurotoxicity and anticonvulsant drugs: a possible link</article-title>
<source/>
<italic>Reproductive Toxicology</italic>
<year>2014</year>
<volume>48</volume>
<fpage>72</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.reprotox.2014.04.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-84906791060</pub-id>
<pub-id pub-id-type="pmid">24803404</pub-id>
</element-citation>
</ref>
<ref id="B110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.-D.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.-M.</given-names>
</name>
<name>
<surname>Manji</surname>
<given-names>H. K.</given-names>
</name>
</person-group>
<article-title>The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3</article-title>
<source/>
<italic>Journal of Neurochemistry</italic>
<year>2000</year>
<volume>72</volume>
<issue>3</issue>
<fpage>1327</fpage>
<lpage>1330</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0721327.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-0033014180</pub-id>
<pub-id pub-id-type="pmid">10037507</pub-id>
</element-citation>
</ref>
<ref id="B111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phiel</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>E. Y.</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Lazar</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>P. S.</given-names>
</name>
</person-group>
<article-title>Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</article-title>
<source/>
<italic>The Journal of Biological Chemistry</italic>
<year>2001</year>
<volume>276</volume>
<issue>39</issue>
<fpage>36734</fpage>
<lpage>36741</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.m101287200</pub-id>
<pub-id pub-id-type="other">2-s2.0-0035965343</pub-id>
<pub-id pub-id-type="pmid">11473107</pub-id>
</element-citation>
</ref>
<ref id="B112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christianson</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Chesler</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kromberg</surname>
<given-names>J. G. R.</given-names>
</name>
</person-group>
<article-title>Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs</article-title>
<source/>
<italic>Developmental Medicine &amp; Child Neurology</italic>
<year>1994</year>
<volume>36</volume>
<issue>4</issue>
<fpage>361</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="other">2-s2.0-0028220791</pub-id>
<pub-id pub-id-type="pmid">7512516</pub-id>
</element-citation>
</ref>
<ref id="B113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyazaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Narita</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism</article-title>
<source/>
<italic>International Journal of Developmental Neuroscience</italic>
<year>2005</year>
<volume>23</volume>
<issue>2-3</issue>
<fpage>287</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2004.05.004</pub-id>
<pub-id pub-id-type="other">2-s2.0-14644443001</pub-id>
<pub-id pub-id-type="pmid">15749253</pub-id>
</element-citation>
</ref>
<ref id="B114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Przewłocki</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism</article-title>
<source/>
<italic>Neuropsychopharmacology</italic>
<year>2005</year>
<volume>30</volume>
<issue>1</issue>
<fpage>80</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300518</pub-id>
<pub-id pub-id-type="other">2-s2.0-11144259318</pub-id>
<pub-id pub-id-type="pmid">15238991</pub-id>
</element-citation>
</ref>
<ref id="B115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Reuhl</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Cheh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McRae</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Halladay</surname>
<given-names>A. K.</given-names>
</name>
</person-group>
<article-title>A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate</article-title>
<source/>
<italic>Journal of Autism and Developmental Disorders</italic>
<year>2006</year>
<volume>36</volume>
<issue>6</issue>
<fpage>779</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-006-0117-y</pub-id>
<pub-id pub-id-type="other">2-s2.0-33747850275</pub-id>
<pub-id pub-id-type="pmid">16609825</pub-id>
</element-citation>
</ref>
<ref id="B116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison-Uy</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Pleasure</surname>
<given-names>S. J.</given-names>
</name>
</person-group>
<article-title>Wnt signaling and forebrain development</article-title>
<source/>
<italic>Cold Spring Harbor Perspectives in Biology</italic>
<year>2012</year>
<volume>4</volume>
<issue>7</issue>
<pub-id pub-id-type="publisher-id">a008094</pub-id>
<pub-id pub-id-type="doi">10.1101/cshperspect.a008094</pub-id>
<pub-id pub-id-type="other">2-s2.0-84868231671</pub-id>
</element-citation>
</ref>
<ref id="B117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinaldi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kulangara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Antoniello</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Markram</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2007</year>
<volume>104</volume>
<issue>33</issue>
<fpage>13501</fpage>
<lpage>13506</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0704391104</pub-id>
<pub-id pub-id-type="other">2-s2.0-34548085412</pub-id>
<pub-id pub-id-type="pmid">17675408</pub-id>
</element-citation>
</ref>
<ref id="B118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumamaru</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Egashira</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Takamori</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons</article-title>
<source/>
<italic>Neuroscience Letters</italic>
<year>2014</year>
<volume>569</volume>
<fpage>142</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2014.03.066</pub-id>
<pub-id pub-id-type="other">2-s2.0-84898958933</pub-id>
<pub-id pub-id-type="pmid">24708928</pub-id>
</element-citation>
</ref>
<ref id="B119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Demethylation of specific Wnt/<italic>β</italic>-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure</article-title>
<source/>
<italic>The Anatomical Record</italic>
<year>2010</year>
<volume>293</volume>
<issue>11</issue>
<fpage>1947</fpage>
<lpage>1953</lpage>
<pub-id pub-id-type="doi">10.1002/ar.21232</pub-id>
<pub-id pub-id-type="other">2-s2.0-78049484028</pub-id>
<pub-id pub-id-type="pmid">20734317</pub-id>
</element-citation>
</ref>
<ref id="B120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Downregulating the canonical Wnt/<italic>β</italic>-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress</article-title>
<source/>
<italic>Neurochemical Research</italic>
<year>2012</year>
<volume>37</volume>
<issue>7</issue>
<fpage>1409</fpage>
<lpage>1419</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-012-0724-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-84862866769</pub-id>
<pub-id pub-id-type="pmid">22374471</pub-id>
</element-citation>
</ref>
<ref id="B121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive/stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid</article-title>
<source/>
<italic>International Journal of Molecular Medicine</italic>
<year>2015</year>
<volume>35</volume>
<issue>1</issue>
<fpage>263</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.3892/ijmm.2014.1996</pub-id>
<pub-id pub-id-type="other">2-s2.0-84917708647</pub-id>
<pub-id pub-id-type="pmid">25384498</pub-id>
</element-citation>
</ref>
<ref id="B122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Nagarajan</surname>
<given-names>V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling</article-title>
<source/>
<italic>The Pharmacogenomics Journal</italic>
<year>2012</year>
<volume>12</volume>
<issue>4</issue>
<fpage>328</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1038/tpj.2011.9</pub-id>
<pub-id pub-id-type="other">2-s2.0-84864334532</pub-id>
<pub-id pub-id-type="pmid">21383773</pub-id>
</element-citation>
</ref>
<ref id="B123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Melton</surname>
<given-names>D. A.</given-names>
</name>
</person-group>
<article-title>A molecular mechanism for the effect of lithium on development</article-title>
<source/>
<italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>1996</year>
<volume>93</volume>
<issue>16</issue>
<fpage>8455</fpage>
<lpage>8459</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.93.16.8455</pub-id>
<pub-id pub-id-type="other">2-s2.0-0029776032</pub-id>
<pub-id pub-id-type="pmid">8710892</pub-id>
</element-citation>
</ref>
<ref id="B124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kataoka</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism</article-title>
<source/>
<italic>Pharmacology Biochemistry and Behavior</italic>
<year>2014</year>
<volume>126</volume>
<fpage>43</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2014.08.013</pub-id>
<pub-id pub-id-type="other">2-s2.0-84907270678</pub-id>
</element-citation>
</ref>
<ref id="B125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Beresford</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Bunker</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder</article-title>
<source/>
<italic>Journal of Child and Adolescent Psychopharmacology</italic>
<year>2014</year>
<volume>24</volume>
<issue>7</issue>
<fpage>399</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1089/cap.2014.0019</pub-id>
<pub-id pub-id-type="other">2-s2.0-84907029014</pub-id>
<pub-id pub-id-type="pmid">25093602</pub-id>
</element-citation>
</ref>
<ref id="B126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats</article-title>
<source/>
<italic>Frontiers in Behavioral Neuroscience</italic>
<year>2014</year>
<volume>8, article 234</volume>
<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00234</pub-id>
<pub-id pub-id-type="other">2-s2.0-84903457535</pub-id>
</element-citation>
</ref>
<ref id="B127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.-H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C. B.</given-names>
</name>
</person-group>
<article-title>Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome</article-title>
<source/>
<italic>Neurobiology of Disease</italic>
<year>2012</year>
<volume>45</volume>
<issue>3</issue>
<fpage>1145</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.12.037</pub-id>
<pub-id pub-id-type="other">2-s2.0-84862783882</pub-id>
<pub-id pub-id-type="pmid">22227453</pub-id>
</element-citation>
</ref>
<ref id="B128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.-H.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>D.-M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C. B.</given-names>
</name>
</person-group>
<article-title>Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome</article-title>
<source/>
<italic>International Journal of Neuropsychopharmacology</italic>
<year>2011</year>
<volume>14</volume>
<issue>5</issue>
<fpage>618</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1017/s1461145710000520</pub-id>
<pub-id pub-id-type="other">2-s2.0-79956052512</pub-id>
<pub-id pub-id-type="pmid">20497624</pub-id>
</element-citation>
</ref>
<ref id="B129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seese</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Maske</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gall</surname>
<given-names>C. M.</given-names>
</name>
</person-group>
<article-title>Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism</article-title>
<source/>
<italic>Neuropsychopharmacology</italic>
<year>2014</year>
<volume>39</volume>
<issue>7</issue>
<fpage>1664</fpage>
<lpage>1673</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2014.13</pub-id>
<pub-id pub-id-type="other">2-s2.0-84900554576</pub-id>
<pub-id pub-id-type="pmid">24448645</pub-id>
</element-citation>
</ref>
<ref id="B130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuskaitis</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Mines</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Jope</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome</article-title>
<source/>
<italic>Biochemical Pharmacology</italic>
<year>2010</year>
<volume>79</volume>
<issue>4</issue>
<fpage>632</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2009.09.023</pub-id>
<pub-id pub-id-type="other">2-s2.0-71549145629</pub-id>
<pub-id pub-id-type="pmid">19799873</pub-id>
</element-citation>
</ref>
<ref id="B131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandhi</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Kogan</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Messier</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice</article-title>
<source/>
<italic>Frontiers in Cellular Neuroscience</italic>
<year>2014</year>
<volume>8, article 70</volume>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00070</pub-id>
<pub-id pub-id-type="other">2-s2.0-84896913124</pub-id>
</element-citation>
</ref>
<ref id="B132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gass</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>M. F.</given-names>
</name>
</person-group>
<article-title>Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP</article-title>
<source/>
<italic>European Journal of Pharmacology</italic>
<year>2008</year>
<volume>584</volume>
<issue>2-3</issue>
<fpage>253</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2008.02.032</pub-id>
<pub-id pub-id-type="other">2-s2.0-41249087635</pub-id>
<pub-id pub-id-type="pmid">18346726</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Wnt/<italic>β</italic>-catenin signaling in ASDs. Wnt binding to FZD-LRP5/6 complex receptor at the membrane recruits the destruction complex and inhibits GSK3<italic>β</italic> activity thus stabilizing <italic>β</italic>-catenin in the cytoplasm and nucleus. Activation of the Wnt/<italic>β</italic>-catenin pathway facilitates synaptic plasticity through the activation of voltage gated ion channels that allows activation of CAMK and CREB mediated transcription. Mutations in TSC associated with ASD prevent <italic>β</italic>-catenin degradation which results in a gain of function of the Wnt pathway. In the presynaptic terminal cadherin mediated cell adhesion between synapses is weakened by phosphorylation of <italic>β</italic>-catenin and synaptic vesicle clustering is enhanced through DVL1. Clustering is also dependent on NLGN/NRXN cell adhesion complexes. Both lithium (LiCl) and VPA activate Wnt/<italic>β</italic>-catenin signaling through inhibition of GSK3<italic>β</italic> activity. Conversely, in the absence of a Wnt ligand, activated GSK3<italic>β</italic> targets <italic>β</italic>-catenin for proteosome-mediated degradation. Mutations associated with DISC1 fail to inhibit GSK3<italic>β</italic> and thus activate Wnt/<italic>β</italic>-catenin pathway. In the presynaptic side Wnt signaling buffering of synaptic vesicles is inhibited and adherens junctions mediated by cadherins are strengthened.</p>
</caption>
<graphic xlink:href="NP2016-9603751.001"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>